Clinova is a pharmaceutical group focused on developing, manufacturing and marketing a broad range of pharmaceutical products and diagnostic devices. Clinova has its global headquarters in Southampton. The company was founded by a group of pharmacists who are all directors on the current management board. Clinova has a robust R & D ability with specific proficiency in technically demanding products. Clinova will utilise its research and development infrastructure to develop a broad range of products that satisfy unmet therapeutic needs. We are dedicated in establishing safe and efficacious products of the uppermost quality. The company is rapidly developing its vision of being a reputable developer and marketer of pharmaceutical products and is committed to the accelerated commercialisation of a range of pharmaceutical products. Our lead programme is the development of a range of preventative masks against avian flu. The Group has also expanded its research to develop and market a drug-testing device. With a view to encouraging exploratory research and identifying future product opportunities the Company s strategy is to develop products through innovation and collaboration with various research institutes and then be active in sales and marketing of the finalised product. To enhance the potential for future growth Clinova is actively searching to acquire further development projects as well as carrying out on-going research and development.